HotSpot Therapeutics Appoints Paul Thibodeau, Ph.D., as Chief Business Officer
BOSTON, July 25, 2022 -- (Healthcare Sales & Marketing Network) -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of small molecule allosteric therapies for the treatment of cancer and autoimmune diseases, tod... Biopharmaceuticals, Personnel HotSpot Therapeutics, allosteric medicine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Autoimmune Disease | Biotechnology | Cancer | Cancer & Oncology | Marketing | Pharmaceuticals